Skip to main content
胜

胜景山河 — Investor Relations & Filings

Ticker · 002525 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 30 across all filing types
Latest filing 2011-04-07 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002525

About 胜景山河

Hunan Shengjing Shanhe Biological Technology Co., Ltd. specializes in the research, development, production, and distribution of yellow rice wine. The company utilizes traditional brewing techniques integrated with modern biological technology to produce a variety of rice wine products under its flagship brand. Its product portfolio includes premium aged yellow rice wines characterized by distinct regional flavors and artisanal quality. Shengjing Shanhe focuses on the domestic market, targeting consumers seeking traditional Chinese alcoholic beverages. The company emphasizes quality control and the preservation of cultural heritage in its manufacturing processes, aiming to innovate within the traditional wine sector through scientific research and product diversification.

Recent filings

Filing Released Lang Actions
关于首次公开发行股票申请未通过会后事项发审委会议审核的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the outcome of a regulatory review meeting by the China Securities Regulatory Commission (CSRC) about the company's initial public offering (IPO) application, which was not approved. It references a specific regulatory meeting and the decision not to approve the IPO. The document is short (512 characters) and serves as a formal announcement of the meeting result and subsequent obligations, not a detailed report or financial statement. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2011-04-07 Chinese
暂缓上市公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from a company regarding the postponement of its listing (IPO) on the stock exchange. It states that the company has applied to delay the listing due to pending matters. The document is very brief (189 characters) and does not contain financial statements or detailed financial data. It is an official notice about a capital market event (listing delay), which fits best under a Regulatory Filing (RNS) as it does not match other more specific categories like Capital/Financing Update (CAP) or Delisting Announcement (DLST).
2010-12-16 Chinese
首次公开发行股票上市公告书
Regulatory Filings Classification · 95% confidence The document is titled as a "首次公开发行股票上市公告书" which translates to "Initial Public Offering (IPO) Stock Listing Announcement." It contains detailed information about the company's IPO, including stock issuance, pricing, shareholder lock-up commitments, financial data for the first three quarters of 2010 (unaudited), and other relevant disclosures required for a stock listing. The document includes financial statements and operational data but is primarily focused on the stock listing event and related disclosures rather than a full annual or quarterly report. It is not a transcript, management change, or legal proceeding. The document is over 10,000 characters and contains substantive financial data and company information related to the IPO and stock listing. This type of document is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement related to the IPO and stock listing, not a full annual or interim report or earnings release. It is not a report publication announcement since it contains detailed data and disclosures itself, not just a notice of report availability.
2010-12-15 Chinese
湖南启元律师事务所关于公司首次公开发行的股票并在深圳证券交易所上市的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the company's initial public offering (IPO) and listing on the Shenzhen Stock Exchange. It discusses the approval from the China Securities Regulatory Commission, compliance with relevant laws and regulations, verification of the company's qualifications for listing, and the legal basis for the IPO. The document is not a financial report, earnings release, or management discussion, but a legal opinion related to the capital market transaction of the company's IPO and listing. This type of document is best classified under Regulatory Filings (RNS) as it is a regulatory compliance document and legal opinion rather than a financial report or announcement of voting results or capital changes.
2010-12-15 Chinese
2010年第一次临时股东大会决议
Regulatory Filings
2010-12-15 Chinese
平安证券有限责任公司关于公司股票上市保荐书
Regulatory Filings Classification · 95% confidence The document is titled as a "股票上市保荐书" which translates to "Stock Listing Sponsorship Letter" or "Sponsorship Document for Stock Listing." It is issued by a securities company (平安证券有限责任公司) recommending the stock listing of 湖南胜景山河生物科技股份有限公司 on the Shenzhen Stock Exchange. The document contains detailed information about the issuer, financial data audited by an accounting firm, issuance details, underwriting, lock-up commitments, and the sponsor's confirmation of compliance with relevant laws and regulations. It is a formal sponsorship letter required for the IPO process in China, not a financial report like an annual or interim report, nor an earnings release or other categories. It is a regulatory filing related to the IPO process and stock listing approval. The document is lengthy (8201 characters) and contains substantive content, not a brief announcement or certification. Therefore, the best fitting category is Regulatory Filings (RNS).
2010-12-15 Chinese

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.